About biocheckinc.com
biocheckinc.com is a Healthcare company based in Foster City (United States) founded in 1997, and was acquired by OriGene in February 2014. In-vitro diagnostic kits and research reagents are developed and marketed. The company has 39 employees. biocheckinc.com has completed 1 acquisition, including DRG International. biocheckinc.com offers products and services including HYBRiD XL®, Antibodies, ELISA Kits, and DS2®. Its focus areas include Diversified Diagnostics, Life Sciences, Life Sciences Platforms and Tools and Research Reagents and Kits. Its legal entity is BIOCHECK, INC. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
BioCheck is engaged in the development, manufacturing and marketing of diagnostic kits and research related reagents. The companys product portfolio includes a wide range of reagents, such as antibodies, antibodies positive human serums, tumor markers, conjugates, diluents, etc. It also offers over 40 EIA test kits covering a wide range of disease areas (cardiac markers, fertility, steroids, thyroid, tumor markers,torch and other infectious diseases). Out of 40, only 17 have been FDA cleared. The other services offered by the company includes custom assay development, antibody conjugation, and contract manufacturing. The company was acquired by OriGene Technologies, on February 26, 2014, and currently working as its subsidiary.
- Headquarters Foster City, United States
- Employees 39
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website biocheckinc.com
- Acquired by OriGene (Feb 2014)
- Legal Name Biocheck, Inc.
- Investors
- Employee Count39
- Investments & Acquisitions
- Acquired byOriGene
(Feb 2014)
Products & Services of biocheckinc.com
biocheckinc.com offers a comprehensive portfolio of products and services, including HYBRiD XL®, Antibodies, ELISA Kits, and DS2®.
Automated analyzer for immunoassays and clinical chemistry testing.
Specialized antibodies for medical research and diagnostics applications.
Kits for detecting specific biomarkers in clinical settings.
System for routine and research immunoassay applications.
Investors in biocheckinc.com
biocheckinc.com has secured backing from 1 investor. Prominent investors backing the company include OriGene.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Proteins, antibodies, and molecular tools are manufactured for research applications. | 1996 | origene.com | Rockville, United States |
Investor details for biocheckinc.com
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by biocheckinc.com
biocheckinc.com has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include DRG International.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Manufacturer and supplier of immunodiagnostic products | drg-international.com | Springfield, United States | 1970 | Aug 2021 | •••• |
Complete acquisition details for biocheckinc.com
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of biocheckinc.com
3 dated milestones of biocheckinc.com across 24 years, from founding to its latest funding, stage changes and deals.
- Founded biocheckinc.com is founded.
- Exit Acquired by OriGene.
- Acquisition Acquires DRG International.
Competitors of biocheckinc.com
biocheckinc.com has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of biocheckinc.com
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of biocheckinc.com
The website of biocheckinc.com (biocheckinc.com) receives about 2K visits a month.
- Monthly visits2K
▲ 47.8% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as biocheckinc.com (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biocheckinc.Com
Complete news archive for biocheckinc.com
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about biocheckinc.com
biocheckinc.com was founded in 1997.
biocheckinc.com is headquartered in Foster City, United States. It is registered at Foster City, California, United States.
biocheckinc.com has 39 employees.
BioCheck is engaged in the development, manufacturing and marketing of diagnostic kits and research related reagents. The companys product portfolio includes a wide range of reagents, such as antibodies, antibodies positive human serums, tumor markers, conjugates, diluents, etc. It also offers over 40 EIA test kits covering a wide range of disease areas (cardiac markers, fertility, steroids, thyroid, tumor markers,torch and other infectious diseases). Out of 40, only 17 have been FDA cleared. The other services offered by the company includes custom assay development, antibody conjugation, and contract manufacturing. The company was acquired by OriGene Technologies, on February 26, 2014, and currently working as its subsidiary.
biocheckinc.com's top competitors include GenScript, Epitomics and Vector Laboratories.
biocheckinc.com offers HYBRiD XL®, Antibodies, ELISA Kits, and DS2®.
biocheckinc.com has made 1 acquisition, including DRG International.
biocheckinc.com has 1 investor. Key investors include OriGene.
biocheckinc.com operates through Biocheck, Inc..
Yes. biocheckinc.com was acquired by OriGene in February 2014.